浙江中医学院学报
浙江中醫學院學報
절강중의학원학보
JOURNAL OF ZHEJIANG COLLEGE OF TRADITIONAL CHINESE MEDICINE
2001年
1期
55-57
,共3页
刘建%彭东信%刘晓睛%朱朝霞%车东媛%赵时宇
劉建%彭東信%劉曉睛%硃朝霞%車東媛%趙時宇
류건%팽동신%류효정%주조하%차동원%조시우
双黄连粉针剂%肺炎支原体%肺间质纤维化%血小板衍生生长因子-BB
雙黃連粉針劑%肺炎支原體%肺間質纖維化%血小闆衍生生長因子-BB
쌍황련분침제%폐염지원체%폐간질섬유화%혈소판연생생장인자-BB
为探讨中药制剂双黄连粉针剂(双黄连)对反复肺炎支原体肺部感染大鼠肺组织中血小板衍生生长因子-BB(PDGF-BB)蛋白质水平表达的影响,给大鼠于24周内反复9次经超声雾化吸入肺炎支原体以复制其慢性肺部感染模型,并应用双黄连腹腔注射进行治疗干预;随后用PDGF-BB单克隆抗体按SABc法行免疫组织化学染色,定量图像分析。结果:(1)感染组动物(n=4)支气管肺泡灌洗液肺炎支原体-PCR检测均为阳性,而对照组(n=4)和感染加双黄连治疗组(n=4)均为阴性(均为P<0.05);三组动物的支气管和肺组织常规细菌培养结果均为阴性;感染组动物透射电镜检查见肺泡间隔增宽,其中有较多胶原纤维堆积,其余两组则未见明显异常。(2)感染组动物肺间质结缔组织中以及小气道和小血管的壁上可见较强的细颗粒状或细丝网状棕黄色PDGF-BB免疫组化染色阳性表达产物,其积分光密度为23.26±3.87(n=4),显著高于正常对照组者(1.52±0.61,n=4,P<0.05)和感染加双黄连治疗组者(3.49±0.63,n=4,P<0.05)。提示双黄连可抑制反复肺炎支原体肺部感染大鼠肺组织中PDGF-BB蛋白质水平的表达,对于防止肺炎支原体肺部感染所引起的肺间质纤维化可能具有一定的作用。
為探討中藥製劑雙黃連粉針劑(雙黃連)對反複肺炎支原體肺部感染大鼠肺組織中血小闆衍生生長因子-BB(PDGF-BB)蛋白質水平錶達的影響,給大鼠于24週內反複9次經超聲霧化吸入肺炎支原體以複製其慢性肺部感染模型,併應用雙黃連腹腔註射進行治療榦預;隨後用PDGF-BB單剋隆抗體按SABc法行免疫組織化學染色,定量圖像分析。結果:(1)感染組動物(n=4)支氣管肺泡灌洗液肺炎支原體-PCR檢測均為暘性,而對照組(n=4)和感染加雙黃連治療組(n=4)均為陰性(均為P<0.05);三組動物的支氣管和肺組織常規細菌培養結果均為陰性;感染組動物透射電鏡檢查見肺泡間隔增寬,其中有較多膠原纖維堆積,其餘兩組則未見明顯異常。(2)感染組動物肺間質結締組織中以及小氣道和小血管的壁上可見較彊的細顆粒狀或細絲網狀棕黃色PDGF-BB免疫組化染色暘性錶達產物,其積分光密度為23.26±3.87(n=4),顯著高于正常對照組者(1.52±0.61,n=4,P<0.05)和感染加雙黃連治療組者(3.49±0.63,n=4,P<0.05)。提示雙黃連可抑製反複肺炎支原體肺部感染大鼠肺組織中PDGF-BB蛋白質水平的錶達,對于防止肺炎支原體肺部感染所引起的肺間質纖維化可能具有一定的作用。
위탐토중약제제쌍황련분침제(쌍황련)대반복폐염지원체폐부감염대서폐조직중혈소판연생생장인자-BB(PDGF-BB)단백질수평표체적영향,급대서우24주내반복9차경초성무화흡입폐염지원체이복제기만성폐부감염모형,병응용쌍황련복강주사진행치료간예;수후용PDGF-BB단극륭항체안SABc법행면역조직화학염색,정량도상분석。결과:(1)감염조동물(n=4)지기관폐포관세액폐염지원체-PCR검측균위양성,이대조조(n=4)화감염가쌍황련치료조(n=4)균위음성(균위P<0.05);삼조동물적지기관화폐조직상규세균배양결과균위음성;감염조동물투사전경검사견폐포간격증관,기중유교다효원섬유퇴적,기여량조칙미견명현이상。(2)감염조동물폐간질결체조직중이급소기도화소혈관적벽상가견교강적세과립상혹세사망상종황색PDGF-BB면역조화염색양성표체산물,기적분광밀도위23.26±3.87(n=4),현저고우정상대조조자(1.52±0.61,n=4,P<0.05)화감염가쌍황련치료조자(3.49±0.63,n=4,P<0.05)。제시쌍황련가억제반복폐염지원체폐부감염대서폐조직중PDGF-BB단백질수평적표체,대우방지폐염지원체폐부감염소인기적폐간질섬유화가능구유일정적작용。
In order to investigate the effects of Shuanghuanglian on the expression of platelet-derived growth factor-BB (PDGF-BB)
in the lung tissue from rats repeatedly infected with mycoplasma pneumoniae (MP), the authors made a rat MP-infection model
by infecting rats with MP for 9 times during a period of 24 weeks with a technique of ultrasonic nebulizing inhalation and treat
ed the rats with Shuanghuanglian by peritoneal injection. Then immunohistochemical stain was performed with PDGF-BB mon
oclone antibody and the results were quantitatively analyzed. The results showed that (1) MP polymerase chain reaction
(PCR) tests indicated positive effectiveness in the bronchoalveolar lavage fluid (BALF) from all of the MP-infected rats (n=
4 ) while they were all negative in BALF from the control animals (n=4, P<0. 05) and in BALF from those rats both infected
with MP, and at the same time, treated with Shuanghuanglian (n= 4, P<0.05). Bacterial cultures of the bronchial and lung
tissue were negative in all three groups. The observation with transmission electron microscope found that the interalveolar
septa were widened with increased amount of collagen in the MP-infected rats while there were no obvious abnormalities in the
other two groups. (2) Strong positive stain of PDGF-BB protein was found in the interstitial connective tissue, the airway wall
and the wall of blood vessels in the lung tissue from the MP-infected animals with the integral optical densities being 23. 26±
3.87 (n=4) which was significantly higher than the values of control group (1.52±0.61, n=4, P<0.05) and of the group
with MP-infection plus Shuanghuanglian treatment (3.49±0.63, n=4, P<0.05). These results suggest that Shuanghuanlian
can inhibit the overexpression of PDGF-BB in the lung tissue of rats with MP-infection,which may be helpful for the prevention
and treatment of pulmonary interstitial fibrosis caused by the repeated MP-infection.